Loading company…
Wuhan Wei Ke Medical Technology develops medical devices for structural heart disease, including atrial shunts and occluders.
Based in Wuhan, China and established in 2018, Wuhan Wei Ke Medical Technology researches, develops and sells three types of medical devices. Its products include an atrial shunt, a cardiac occluder delivery system, a nanomembrane patent foramen ovale occluder and an atrial septal puncture system. The company has completed four funding rounds as of 2021 and has applied for 35 patents. It plans to use its Series B funding to advance minimally invasive interventional products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in